About the journal
Journal of the National Comprehensive Cancer Network is a journal published by National Comprehensive Cancer. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- National Comprehensive Cancer
- ISSN
- 1540-1405 · 1540-1413
- Access
- Not open access / not declared
- Official website
- http://www.jnccn.org
Index listings
- MEDLINE · 2003-01-01
- PUBMED · 2009-12-29
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 139 days received→accepted — computed from PubMed (n=55)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
5261
Last recorded publication year
2026
h-index
202
i10-index
1746
From OpenAlex open data (CC0).
Editorial & policy4
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 38%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101162515
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Cancer survivorship and care
- Cancer survivorship and care
Show all subjects (50)
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Palliative Care and End-of-Life Issues
- Lymphoma Diagnosis and Treatment
- Palliative Care and End-of-Life Issues
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Pancreatic and Hepatic Oncology Research
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Prostate Cancer Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Prostate Cancer Diagnosis and Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ